2.43
price up icon3.85%   0.09
after-market After Hours: 2.39 -0.04 -1.65%
loading
Ac Immune Sa stock is traded at $2.43, with a volume of 356.47K. It is up +3.85% in the last 24 hours and up +15.44% over the past month. AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.34
Open:
$2.3
24h Volume:
356.47K
Relative Volume:
2.72
Market Cap:
$244.00M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-3.4249
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
+17.39%
1M Performance:
+15.44%
6M Performance:
-10.99%
1Y Performance:
-31.16%
1-Day Range:
Value
$2.26
$2.50
1-Week Range:
Value
$2.02
$2.50
52-Week Range:
Value
$1.4299
$4.26

Ac Immune Sa Stock (ACIU) Company Profile

Name
Name
Ac Immune Sa
Name
Phone
-
Name
Address
-
Name
Employee
172
Name
Twitter
@AC_Immune_SA
Name
Next Earnings Date
2025-04-28
Name
Latest SEC Filings
Name
ACIU's Discussions on Twitter

Compare ACIU with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACIU
Ac Immune Sa
2.43 232.39M 0 -60.14M -68.17M -0.7095
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Ac Immune Sa Stock (ACIU) Upgrades & Downgrades

Date Action Analyst Rating Change
May-31-24 Initiated BTIG Research Buy
Feb-01-19 Downgrade UBS Buy → Neutral
Jan-04-19 Initiated UBS Buy
Apr-05-18 Initiated H.C. Wainwright Buy
Mar-23-18 Downgrade Credit Suisse Outperform → Neutral
Oct-18-16 Initiated Credit Suisse Outperform
Oct-18-16 Initiated Jefferies Buy
Oct-18-16 Initiated Leerink Partners Outperform
View All

Ac Immune Sa Stock (ACIU) Latest News

pulisher
12:08 PM

Is AC Immune SA stock a growth or value playFree Consultation - jammulinksnews.com

12:08 PM
pulisher
Jul 23, 2025

Published on: 2025-07-23 19:50:12 - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives AC Immune SA stock priceConsistent triple-digit returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about AC Immune SA stockUnprecedented growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

AC Immune SA Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is AC Immune SA a good long term investmentConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech

Jul 17, 2025
pulisher
Jul 15, 2025

How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AC Immune SA stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jun 30, 2025

Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech

Jun 30, 2025
pulisher
Jun 19, 2025

AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks

Jun 19, 2025
pulisher
Jun 16, 2025

Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

AC Immune SA Announces Executive Changes - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

AC Immune SA Announces Leadership Changes in Development Team - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st

Jun 11, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

June 2025 Penny Stocks With Promising Potential - simplywall.st

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025
pulisher
Jun 03, 2025

ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com

Jun 03, 2025
pulisher
May 29, 2025

Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World

May 29, 2025
pulisher
May 21, 2025

Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st

May 21, 2025
pulisher
May 21, 2025

TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient

May 21, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World

May 17, 2025
pulisher
May 15, 2025

AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World

May 15, 2025
pulisher
May 13, 2025

AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN

May 13, 2025

Ac Immune Sa Stock (ACIU) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Cap:     |  Volume (24h):